# Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment

> **NCT04264260** · PHASE2 · COMPLETED · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 42 (actual)

## Conditions studied

- Hepatocellular Carcinoma Stage IIIB
- Cholangiocarcinoma, Intrahepatic
- Cholangiocarcinoma; With Hepatocellular Carcinoma
- Hepatocellular Carcinoma Stage IV

## Interventions

- **DRUG:** Colchicine Tablets

## Key facts

- **NCT ID:** NCT04264260
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-24
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2025-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04264260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04264260, "Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04264260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*